In the present study, we found that GRN A displayed potent anticancer effect in vivo; treatment of the mice bearing hepatocellular carcinoma HegG2 cancer cells with GRN A resulted in a significant inhibitory effect on tumor growth (Figure 5). Here, GRN is linked to neoplasm.